Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Figure 2: Mechanism of activation of JAK2 kinase activity by mutations in the JAK2 signalling pathway.

Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...

Dizal announces new findings on golidocitinib; to present clinical results at ELCC 2025 in Paris on March 26-29: Shanghai Saturday, March 22, 2025, 17:00 Hrs [IST] Dizal, a biopha ...